LIMERICK, Ireland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF), the global leader in digital validation and quality process automation, today announced a Master Services Agreement with one of the world’s leading providers of biopharma research and manufacturing technologies (“the Company”). Headquartered in Europe and operating across more than 60 global locations, this 13,000+ employee organization will begin deploying Kneat’s platform for equipment validation at several of ...

Core Insights - Kneat.com, inc. has signed a three-year Master Services Agreement with a major specialty chemicals manufacturer, enhancing its momentum in new customer acquisitions for 2025 [1][3] - The agreement is expected to drive the deployment of Kneat Gx across critical functions such as Computer System Validation, Equipment Validation, and electronic logbooks [2] Company Overview - Kneat Solutions specializes in digital validation and quality process automation, serving highly regulated industries [4] - The company’s platform, Kneat Gx, is fully certified and compliant with ISO 9001, ISO 27001, and 21 CFR Part 11/Annex 11 [4] - Kneat Gx has demonstrated significant efficiency improvements, reducing man-hours for validation documentation by up to 50% and accelerating review and approval cycles by up to 50% [4] Market Position - Kneat has achieved record new customer acquisitions in 2025, driven by strong demand and a high win rate against competitors [3] - The platform is recognized for its ease of use, no-code configurability, and reliable data integrity, positioning Kneat as a leader in the digital validation market [3]

Core Insights - Kneat will present at the Emerging Growth Conference on September 24, 2025, providing an opportunity for real-time interaction with CEO Eddie Ryan [1][2] - The presentation will cover Kneat's progress as a fast-growing software company focused on digitizing validation processes for life sciences [5][8] Company Overview - Kneat is a leader in digitizing and automating validation and quality processes, offering a no-code, highly configurable software platform [1][5] - The company's platform, Kneat Gx, is designed to replace paper documentation with real-time data capture, enhancing speed, precision, and transparency in validation processes [7][8] - Kneat Gx is fully compliant with ISO 9001, ISO 27001, and 21 CFR Part 11/Annex 11 standards, ensuring high regulatory compliance [9] Performance Metrics - Kneat Gx has been shown to reduce labor hours associated with validation documentation by over 50% and accelerate review and approval cycles by up to 50% [9] - The platform is utilized by many of the world's leading life sciences companies, including major pharmaceutical firms, to enhance their quality validation processes [8][9]

Core Insights - Kneat.com, inc. is on a trajectory towards profitability, achieving record new customer wins and welcoming new leadership in key areas [2][10] - The company reported significant financial growth in Q2 2025, with total revenue reaching $15.4 million, a 32% increase year over year [7][8] Financial Highlights - Q2 2025 total revenue was $15.4 million, up from $11.7 million in Q2 2024, marking a 32% increase [8] - SaaS revenue for Q2 2025 grew 31% to $14.1 million compared to $10.8 million in Q2 2024 [8] - Gross profit for Q2 2025 was $11.6 million, a 34% increase from $8.7 million in Q2 2024, with a gross margin of 75% [8] - Annual Recurring Revenue (ARR) as of June 30, 2025, was $64.8 million, reflecting a 43% year-over-year growth from $45.4 million [7][8] Business Developments - In April 2025, Kneat signed a Services Agreement with a multinational generic pharmaceuticals producer to digitize its drawing management process [13] - The company launched Kneat Gx 9.5 in July 2025, enhancing data management capabilities and supporting risk-based validation processes [13] - Kneat expanded its executive leadership team, appointing a new Chief Innovation Officer and a new Chief Product Officer [13] Operational Performance - For the first half of 2025, total revenue increased 34% to $30.2 million compared to $22.4 million in the same period of 2024 [9] - Net income for the first half of 2025 was $1.8 million, a significant improvement from a net loss of $6.4 million in the first half of 2024 [9]

Core Viewpoint - Kneat.com, Inc. is set to release its financial results for the quarter ended June 30, 2025, on August 5, 2025, after the TSX market close [1] Financial Results Announcement - The financial results will be available on the Investors page of the Kneat Solutions website [3] - A conference call and Q&A session for sell-side analysts will be hosted by the CEO and CFO on August 6, 2025, at 09:00 ET [2] Company Overview - Kneat Solutions specializes in digitizing and automating validation and quality processes for highly regulated industries [3] - The company’s digital validation platform, Kneat Gx, is fully certified and compliant with ISO 9001, ISO 27001, and 21 CFR Part 11/Annex 11 [3] - Kneat Gx has demonstrated significant efficiency improvements, including up to a 40% reduction in validation cycle times and up to a 20% faster speed to market [3]

Core Insights - Kneat.com, inc. has signed a multi-year Master Services Agreement with a leading healthcare technology and diagnostics company to digitize and automate validation and quality processes [1][2] - The healthcare technology company employs over 50,000 people and operates manufacturing facilities in more than a dozen countries [2] - The agreement will initially focus on digitizing Commissioning, Qualification, and Validation workflows at several key manufacturing sites [2][3] Industry Trends - The trend towards digital validation in the life sciences sector is accelerating, with 93% of organizations either using or planning to use digital validation, up from 86% in 2024 [3] - Digital validation is recognized for delivering speed to market, scalable compliance, and a foundation for future automation and AI innovations [3] Company Performance - Kneat Solutions is noted for its efficiency in validation and compliance through its digital validation platform, Kneat Gx, which is fully certified and compliant with industry standards [4] - Customer studies indicate that Kneat Gx can reduce documentation cycle times by up to 40% and speed to market by up to 20% [4]

Core Viewpoint - Kneat.com, Inc. is set to release its financial results for Q1 2025 on May 7, 2025, after the TSX market close, highlighting the company's ongoing commitment to transparency and investor engagement [1]. Financial Results Announcement - The financial results for the quarter ended March 31, 2025, will be available after the market close on May 7, 2025 [1]. - A conference call and Q&A session for sell-side analysts will be hosted by the CEO and CFO on May 8, 2025, at 09:00 ET [2]. Company Overview - Kneat Solutions specializes in providing digital validation and compliance solutions for highly regulated industries through its platform, Kneat Gx [3]. - The company is recognized for its high customer satisfaction and efficient implementation processes, supported by user-friendly design and expert training [3]. - Kneat Gx is fully certified under ISO 9001 and ISO 27001, and compliant with 21 CFR Part 11/Annex 11, ensuring high standards in validation processes [3]. - Independent studies indicate that Kneat Gx can achieve up to a 40% reduction in documentation cycle times and a 20% faster speed to market [3].